Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Camilla Tøvik Jørgensen"'
Autor:
Brita Tonne, Marit Holmefjord Pedersen, Synne G. Fronas, Camilla Tovik Jorgensen, Erik Koldberg Amundsen, Julie Berge Maehlum, Thea Berg, Aase-Berit Mathisen, Waleed Ghanima, Lamya Garabet
Publikováno v:
Thrombosis Update, Vol 13, Iss , Pp 100147- (2023)
Introduction: D-dimer is a crucial test to exclude deep vein thrombosis (DVT). We aimed to evaluate the performance of three D-dimer assays: STA-Liatest D-Di Plus (Diagnostica Stago), Tina-quant D-Dimer Gen. 2 (Roche Diagnostics), and INNOVANCE D-Dim
Externí odkaz:
https://doaj.org/article/4d21a1d4b4204d1f9f67a2c7dabd38f9
Autor:
Zygimantas Zaboras, Camilla Tøvik Jørgensen, Andreas Stensvold, Heidi Hassel Pettersen, Aleksandra Galovic Grdinic, Sigrid Kufaas Brækkan, Waleed Ghanima, Mazdak Tavoly
Publikováno v:
TH Open, Vol 08, Iss 01, Pp e132-e140 (2024)
Background International guidelines are increasingly recommending direct oral anticoagulants (DOACs) as the first-line treatment for cancer-associated thrombosis (CAT). However, data regarding treatment patterns and adherence to guidelines in patient
Externí odkaz:
https://doaj.org/article/08a03115bfdf4041b564839d425f1229
Autor:
Camilla Tøvik Jørgensen, Mazdak Tavoly, Heidi Hassel Pettersen, Eli Førsund, Christina Roaldsnes, Magnus Kringstad Olsen, Eirik Tjønnfjord, Jostein Gleditsch, Aleksandra Grdinic Galovic, Synne Frønæs Vikum, Sigrid Kufaas Brækkan, Waleed Ghanima
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Purpose The incidence of venous thromboembolism (VTE) is expected to increase over the next decades, further increasing its substantial impact on patients and health care resources. Registries have the benefit of reporting real‐world data
Externí odkaz:
https://doaj.org/article/c596d421ebb64119b44ffdd06613a6f0
Autor:
Tina Margrethe Karlsvik, Thore Langfeldt Borgenvik, Mirjam Aadalen, Kristin Utne, Eli Førsund, Camilla Tøvik Jørgensen, René Holst, Lars‐Petter Jelsness‐Jørgensen, Waleed Ghanima
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 582-585 (2020)
Abstract Background Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in efficacy and safety. In
Externí odkaz:
https://doaj.org/article/bf76f010b7204b7ab11c2c86d8765ac5
Autor:
Hodo Mohamad, Synne Gronvold Fronas, Camilla Tøvik Jørgensen, Mazdak Tavoly, Lamya Garabet, Waleed Ghanima
Publikováno v:
Thrombosis research. 216
Empiric anticoagulation therapy is often used in patients with suspected deep vein thrombosis (DVT) to avoid complications if the workup is delayed. Studies have shown the safety of administering direct oral anticoagulants (DOACs) and low molecular w
Autor:
Frederikus A. Klok, Jostein Gleditsch, Anders E.A. Dahm, Synne G. Fronas, René Holst, Camilla Tøvik Jørgensen, Nezar Raouf, Waleed Ghanima, Hilde Skuterud Wik
Publikováno v:
Blood Advances, 4(20), 5002-5010. AMER SOC HEMATOLOGY
Blood Adv
Blood Adv
Guidelines for the diagnostic workup of deep vein thrombosis (DVT) recommend assessing the clinical pretest probability before proceeding to D-dimer testing and/or compression ultrasonography (CUS) if the patient has high pretest probability or posit
Autor:
Lamya, Garabet, Anna, Eriksson, Eirik, Tjønnfjord, Xue-Yan, Cui, Magnus Kringstad, Olsen, Hege Karine, Jacobsen, Camilla Tøvik, Jørgensen, Åse-Berit, Mathisen, Marie-Christine, Mowinckel, Maria Therese, Ahlen, Ingvild Hausberg, Sørvoll, Kjersti Daae, Horvei, Siw Leiknes, Ernstsen, Ingvild Jenssen, Lægreid, Benedicte, Stavik, René, Holst, Per Morten, Sandset, Waleed, Ghanima
Background: SARS-CoV-2 adenoviral vector DNA vaccines have been linked to the rare but serious thrombotic postvaccine complication vaccine-induced immune thrombotic thrombocytopenia. This has raised concerns regarding the possibility of increased thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5f12bb44af7ba702666d9034e5b98e
https://hdl.handle.net/10037/28790
https://hdl.handle.net/10037/28790
Autor:
Brita Tonne, Marit Holmefjord Pedersen, Synne G. Fronas, Camilla Tovik Jorgensen, Erik Koldberg Amundsen, Julie Berge Maehlum, Thea Berg, Aase-Berit Mathisen, Waleed Ghanima, Lamya Garabet
Publikováno v:
Thrombosis Update, Vol 15, Iss , Pp 100178- (2024)
Externí odkaz:
https://doaj.org/article/a196cac056d5430fa495dfe96b253380
Autor:
Nezar Raouf, Hilde Skuterud Wik, Anders E.A. Dahm, Synne G. Fronas, Jostein Gleditsch, Frederikus A. Klok, Waleed Ghanima, René Holst, Camilla Tøvik Jørgensen
Publikováno v:
Blood Adv
Blood Advances, 4(11), 2468-2476. AMER SOC HEMATOLOGY
Blood Advances, 4(11), 2468-2476. AMER SOC HEMATOLOGY
Guidelines suggest using empiric low-molecular-weight heparin if the diagnostic workup of deep vein thrombosis (DVT) is expected to be delayed. The role of direct oral anticoagulants for deferred compression ultrasound imaging (CUS) in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad4989c0e244d5c593a57b38c0e7fe2
http://hdl.handle.net/10852/85522
http://hdl.handle.net/10852/85522
Autor:
Synne G. Fronas, Jostein Gleditsch, Anders Ea Dahm, Nezar Raouf, Hilde Skuterud Wik, Camilla Tøvik Jørgensen, Erik A Klok, Waleed Ghanima
Background Together with clinical decision rules, D-dimer testing has long been the mainstay of diagnostic work-up of suspected deep vein thrombosis (DVT). Advantages of D-dimer measurement include wide availability, low costs and high sensitivity. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ecf4f7bda2e49b874155285f792351
https://hdl.handle.net/1887/122828
https://hdl.handle.net/1887/122828